A/Prof James McMahon is a dedicated clinician-scientist with a growing national and international reputation for excellence in Infectious Diseases. Prior to completing his PhD at Monash University in 2013, A/Prof McMahon worked as an Infectious Disease Physician at the Alfred Hospital and Monash Medical Centre. He is currently appointed as the Head of the Clinical Research Unit at the Department of Infectious Diseases (Alfred Hospital; Monash Uni).

A/Prof McMahon has received substantial competitive fellowship and grant funding totalling $50,590,729.50 to date, from (including but not limited to) NHMRC Early Career Fellowship, Australian Centre for HIV and Hepatitis Virology Research, NHMRC Program Grant, Melbourne HIV Cure Consortium, MRFF and several charitable foundations.

A/Prof McMahon's research interests include clinical trials focused on HIV and COVID-19. Specific interests include trials in HIV Cure developing non-invasive imaging methods to locate and quantify tissue sites of HIV and clinical trials of interventions targeting the HIV reservoir with latency reversal agents and immunotherapeutics. For COVID-19 he leads an adaptive randomised trial of COVID-19 vaccine booster strategies in immunocompromised hosts and leads randomised trials of antivirals for early disease and a large prospective biobank of biological samples with matched clinical data post infection.

A/Prof McMahon is the current Vice President and President-Elect for Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), sits on the National Clinical Evidence Taskforce committees for COVID-19 Therapeutics and National Monkeypox Taskforce.

A/Prof McMahon is the current President Elect for the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) and is the co-convener for the 2024 conference in Sydney. He has also been invited as a reviewer for the NHMRC Ideas Grant Panel, European Research Council and the MRFF Early to Mid-Career Researchers Grant Panel.

 A/Prof McMahon holds several distinguished positions across various Journals including being part of the Editorial Board on PLoS One and as an Associate Editor of AIDS Research and Therapy.

Other notable services include leading the IAS 2023 Organizing Committee and invitation to the AFAO Expert Advisory panel on strategies to end HIV in Australia by 2025.